Company Filing History:
3 out of 4 
2 out of 1,745 
1 out of 13 Years Active: 2017-2020
Title: The Innovations of Mathieu Barrier
Introduction
Mathieu Barrier is a notable inventor based in Wavrin, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of 3 patents to his name, Barrier's work is recognized for its potential impact on medical science.
Latest Patents
One of his latest patents involves the development of sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine. This invention focuses on the preparation and use of these sulphate salts, along with pharmaceutically acceptable solvates. The patent outlines their application in pharmaceutical compositions aimed at treating and preventing neurodegenerative diseases.
Career Highlights
Throughout his career, Mathieu Barrier has worked with prominent organizations such as Alzprotect and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.
Collaborations
Some of his notable coworkers include Stéphane Burlet and Cécilia Estrella. Their collaborative efforts have likely enhanced the innovative processes within their respective projects.
Conclusion
Mathieu Barrier's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments in neurodegenerative diseases.